The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 09, 2021

Filed:

Apr. 19, 2019
Applicant:

Inivata Ltd., Cambridge, GB;

Inventors:

Samuel Woodhouse, Cambridge, GB;

Stefanie Lensing, Cambridge, GB;

Tim Forshew, Stevenage, GB;

Vincent Plagnol, Cambridge, GB;

Matthew Edward Smith, Cambridge, GB;

Karen Howarth, Cambridge, GB;

Michael Epstein, Cambridge, GB;

Assignee:

INIVATA LTD., Cambridge, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6853 (2018.01); C12Q 1/686 (2018.01); G16B 30/00 (2019.01); C12Q 1/6886 (2018.01); C12Q 1/6806 (2018.01); G16B 20/00 (2019.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/686 (2013.01); C12Q 1/6853 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/16 (2013.01); G16B 20/00 (2019.02); G16B 30/00 (2019.02);
Abstract

The present disclosure relates to methods for detecting and targeting genomic rearrangements, in particular gene fusion events, by targeting a DNA molecule of interest with a set or pool of primers, wherein the forward primers and reverse primers produce a PCR amplification product when a genomic rearrangement is present. The present disclosure also relates to methods of bioinformatic analysis to determine whether or not the detection of an amplification product from the selective PCR is actually indicative of the presence of a gene fusion. The present disclosure also related to related methods of diagnosis and treatment of diseases and conditions associated with such genomic rearrangements, in particular cancers, such as lung cancer.


Find Patent Forward Citations

Loading…